Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes.

Samman Tahhan A, Sandesara P, Hayek SS, Hammadah M, Alkhoder A, Kelli HM, Topel M, O'Neal WT, Ghasemzadeh N, Ko YA, Gafeer MM, Abdelhadi N, Choudhary F, Patel K, Beshiri A, Murtagh G, Kim J, Wilson P, Shaw L, Vaccarino V, Epstein SE, Sperling L, Quyyumi AA.

J Am Heart Assoc. 2018 Feb 21;7(5). pii: e007914. doi: 10.1161/JAHA.117.007914.

2.

Ability of serum C-reactive protein and white blood cell cout in predicting acute schemic stroke. A short -term follow-up study.

Bakhshayesh-Eghbali B, Roudbary SA, Basir Jafari S, Nabizadeh SP, Naderi-Asrami N, Sohrabnejad R.

Caspian J Intern Med. 2016 Summer;7(3):206-210.

3.

Serum from obstructive sleep apnea patients induces inflammatory responses in coronary artery endothelial cells.

Zychowski KE, Sanchez B, Pedrosa RP, Lorenzi-Filho G, Drager LF, Polotsky VY, Campen MJ.

Atherosclerosis. 2016 Nov;254:59-66. doi: 10.1016/j.atherosclerosis.2016.09.017. Epub 2016 Sep 22.

4.

Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era.

Barbero U, D'Ascenzo F, Nijhoff F, Moretti C, Biondi-Zoccai G, Mennuni M, Capodanno D, Lococo M, Lipinski MJ, Gaita F.

Scientifica (Cairo). 2016;2016:3769152. doi: 10.1155/2016/3769152. Epub 2016 Apr 27. Review.

5.

Endophenotypes for Age-Related Macular Degeneration: Extending Our Reach into the Preclinical Stages of Disease.

Gorin MB, Weeks DE, Baron RV, Conley YP, Ortube MC, Nusinowitz S.

J Clin Med. 2014 Nov 28;3(4):1335-56. doi: 10.3390/jcm3041335.

6.

The Anti-Inflammatory Actions of Exercise Training.

Flynn MG, McFarlin BK, Markofski MM.

Am J Lifestyle Med. 2007 May;1(3):220-235.

8.

Impact of Framingham risk score, flow-mediated dilation, pulse wave velocity, and biomarkers for cardiovascular events in stable angina.

Park KH, Han SJ, Kim HS, Kim MK, Jo SH, Kim SA, Park WJ.

J Korean Med Sci. 2014 Oct;29(10):1391-7. doi: 10.3346/jkms.2014.29.10.1391. Epub 2014 Oct 8.

9.

Relationship between C-reactive protein and stroke: a large prospective community based study.

Liu Y, Wang J, Zhang L, Wang C, Wu J, Zhou Y, Gao X, Wang A, Wu S, Zhao X.

PLoS One. 2014 Sep 5;9(9):e107017. doi: 10.1371/journal.pone.0107017. eCollection 2014.

10.

Quantifying cardiometabolic risk using modifiable non-self-reported risk factors.

Marino M, Li Y, Pencina MJ, D'Agostino RB Sr, Berkman LF, Buxton OM.

Am J Prev Med. 2014 Aug;47(2):131-40. doi: 10.1016/j.amepre.2014.03.006. Epub 2014 Jun 17.

11.

Stroke risk after nonstroke emergency department dizziness presentations: a population-based cohort study.

Kerber KA, Zahuranec DB, Brown DL, Meurer WJ, Burke JF, Smith MA, Lisabeth LD, Fendrick AM, McLaughlin T, Morgenstern LB.

Ann Neurol. 2014 Jun;75(6):899-907. doi: 10.1002/ana.24172. Epub 2014 May 26.

12.

The impact of C reactive protein on global cardiovascular risk on patients with coronary artery disease.

Cozlea DL, Farcas DM, Nagy A, Keresztesi AA, Tifrea R, Cozlea L, Carașca E.

Curr Health Sci J. 2013 Oct;39(4):225-31. Epub 2013 Oct 10.

13.

Atherosclerotic biomarkers and aortic atherosclerosis by cardiovascular magnetic resonance imaging in the Framingham Heart Study.

Hong SN, Gona P, Fontes JD, Oyama N, Chan RH, Kenchaiah S, Tsao CW, Yeon SB, Schnabel RB, Keaney JF, O'Donnell CJ, Benjamin EJ, Manning WJ.

J Am Heart Assoc. 2013 Nov 15;2(6):e000307. doi: 10.1161/JAHA.113.000307.

14.

Acute phase reactants as novel predictors of cardiovascular disease.

Ahmed MS, Jadhav AB, Hassan A, Meng QH.

ISRN Inflamm. 2012 May 6;2012:953461. doi: 10.5402/2012/953461. Review.

15.

Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular risk.

McManus DD, Beaulieu LM, Mick E, Tanriverdi K, Larson MG, Keaney JF Jr, Benjamin EJ, Freedman JE.

Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2666-73. doi: 10.1161/ATVBAHA.112.301112. Epub 2013 Aug 22.

16.

Cardiovascular Disease Risk Assessment: Insights from Framingham.

D'Agostino RB Sr, Pencina MJ, Massaro JM, Coady S.

Glob Heart. 2013 Mar;8(1):11-23.

17.

Maternal plasma soluble TRAIL is decreased in preeclampsia.

Chaemsaithong P, Chaiworapongsa T, Romero R, Korzeniewski SJ, Stampalija T, Than NG, Dong Z, Miranda J, Yeo L, Hassan SS.

J Matern Fetal Neonatal Med. 2014 Feb;27(3):217-27. doi: 10.3109/14767058.2013.806906. Epub 2013 Aug 13.

18.

Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community.

Schnabel RB, Yin X, Larson MG, Yamamoto JF, Fontes JD, Kathiresan S, Rong J, Levy D, Keaney JF Jr, Wang TJ, Murabito JM, Vasan RS, Benjamin EJ.

Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1728-33. doi: 10.1161/ATVBAHA.112.301174. Epub 2013 May 2.

19.

Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study.

Fontes JD, Yamamoto JF, Larson MG, Wang N, Dallmeier D, Rienstra M, Schnabel RB, Vasan RS, Keaney JF Jr, Benjamin EJ.

Atherosclerosis. 2013 May;228(1):217-23. doi: 10.1016/j.atherosclerosis.2013.01.019. Epub 2013 Feb 4.

20.

Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy : is there a role for folate?

Burghardt KJ, Ellingrod VL.

Mol Diagn Ther. 2013 Feb;17(1):21-30. doi: 10.1007/s40291-013-0017-8. Review.

Supplemental Content

Support Center